Biotech Investor Adds Million as Krystal Biotech Revenue Rises
A major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
Which Dividend Etf Has Competitive Fees
Identify dividend ETFs with competitive fees and solid value. Learn key criteria and compare options to optimize your costs today.
27,814 articles
What Know About This Fund’S $10.2 Million Hotel Stock Buy
A boutique fund revealed a sizable stake in a hotel stock, signaling interest in the sector’s recovery. Here’s a prac...
Prediction Market Pegs SpaceX's IPO Day: 62% Forecast for $2 Trillion Valuation
A single market signal suggests SpaceX's IPO could roar, but history warns investors not to blindly chase headlines. ...
Could IQIYI Stock Double by 2027? The AI Turnaround Tale
iQIYI is betting on AI to revive growth as its core subscription business falters. With Nadou Pro signing thousands o...
Duolingo's Freemium Model Faces a Major Investor Test
Duolingo built a global audience by offering free lessons and charging a devoted subset of users. As growth slows, in...
Revolution Medicines Billion Market: Why the Valuation Makes Sense
A biotech with no current revenue can still carry a sky-high valuation. This article explains how Revolution Medicine...
Microsoft's Split with OPENAI Could Boost Stock Long-Term
As AI accelerates,Microsoft's split with OPENAI could reshape strategy and investor returns. Learn what this means fo...
OKX Confirms $53 Million Investment to Buy 20% Coinone Stake
OKX is investing $53 million for a 20% stake in Coinone, a move that broadens its footprint in South Korea’s competit...
Broadcom's Future $100 Billion Chip Drive: Buy Now
Broadcom is shifting from a broad tech portfolio to a focused AI chip powerhouse. If the company can turn custom AI c...
Over 100% Year, Should You Buy TSMC Now? Guide
Taiwan Semiconductor Manufacturing Company has delivered remarkable returns, yet the question remains: with a rally l...
Where Will Alphabet Stock Go in 5 Years? A Practical Look
Investors want a clear compass for Alphabet stock in the next five years. This article breaks down the growth drivers...
Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status